The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors

University of Colorado Boulder (CU)

Status: Completed

Conditions: Breast Cancer

Treatments: Behavioral: Education; Behavioral: Values

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT03980093

R21CA218723 (U.S. NIH Grant/Contract)

18-0234

Details and patient eligibility

About

This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).

Enrollment: 88 patients

Sex: Female

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria include:

1. Women in Colorado treated for Stage 0 to III estrogen receptor-positive breast cancer who have completed primary cancer treatment (surgery, chemotherapy, and/or radiation) and within the past 2.5 years, have been prescribed anti-hormonal therapy
2. Take their anti-hormonal therapy medication at least occasionally and have at least 1 more year left on their prescription
3. Report at least 1 factor that makes taking their anti-hormonal therapy medication difficult
4. Have internet access

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

88 participants in 2 patient groups

Education plus Values

Experimental group

Treatment:

Behavioral: Values

Behavioral: Education

Education

Active Comparator group

Treatment:

Behavioral: Education